Erythropoietin and Its Angiogenic Activity
Erythropoietin (EPO) is the main hematopoietic hormone acting on progenitor red blood cells via stimulation of cell growth, differentiation, and anti-apoptosis. However, its receptor (EPOR) is also expressed in various non-hematopoietic tissues, including endothelium. EPO is a pleiotropic growth fac...
Main Authors: | Patrícia Kimáková, Peter Solár, Zuzana Solárová, Radovan Komel, Nataša Debeljak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/7/1519 |
Similar Items
-
Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction
by: Nataša eDebeljak, et al.
Published: (2014-11-01) -
STAT5 as a Key Protein of Erythropoietin Signalization
by: Zuzana Tóthová, et al.
Published: (2021-07-01) -
Erythropoietin Potentiates the Anti-proliferative Effect of Tamoxifen in Ovarian Adenocarcinoma A2780 Cells
by: Patrícia Kimáková, et al.
Published: (2018-12-01) -
The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
by: Zuzana Tóthová, et al.
Published: (2021-07-01) -
Expression of erythropoietin and its receptor increases in colonic neoplastic progression: The role of hypoxia in tumorigenesis
by: Zoltan Gombos, et al.
Published: (2011-01-01)